Piper Sandler analyst David Westenberg maintains IDEXX Laboratories (NASDAQ:IDXX) with a Overweight and raises the price target from $520 to $525.
Piper Sandler Maintains Overweight on IDEXX Laboratories, Raises Price Target to $525
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.